Name | 3,6,7,7a-tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione |
---|---|
Synonyms |
2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole
tetrahydro-pyrrolo[1,2-a]imidazole-2,5-dione dimiracetam 1H-Pyrrolo(1,2-a)imidazole-2,5(3H,6H)-dione,dihydro (+-)-Dihydro-1H-pyrrolo(1,2-a)imidazole-2,5(3H,6H)-dione Dimiracetam [INN] |
Description | Dimiracetam is an orally active compound, with anti-neuropathic activity. Dimiracetam inhibits hypersensitivity and neurological alterations, and inhibits Sorafenib (HY-10201)-induced neuropathy in cold stimulation rat models[1]. |
---|---|
Related Catalog | |
References |
Density | 1.4g/cm3 |
---|---|
Boiling Point | 460.5ºC at 760 mmHg |
Molecular Formula | C6H8N2O2 |
Molecular Weight | 140.14 |
Flash Point | 232.3ºC |
Exact Mass | 140.05900 |
PSA | 52.90000 |
Vapour Pressure | 1.16E-08mmHg at 25°C |
Index of Refraction | 1.585 |
~82% 126100-97-8 |
Literature: Journal of Medicinal Chemistry, , vol. 36, # 26 p. 4214 - 4220 |
~22% 126100-97-8 |
Literature: Journal of Medicinal Chemistry, , vol. 36, # 26 p. 4214 - 4220 |
Precursor 1 | |
---|---|
DownStream 0 |